COLUMBIA, S.C., Jan. 7 /PRNewswire-FirstCall/ -- Collexis Holdings Inc.
(OTC Bulletin Board: CLXS), a leading developer of semantic search and
knowledge discovery software, announced today that their life science research
portal http://www.BiomedExperts.com has surpassed 80,000 registered users.
The unique visitor traffic in December has exploded to over 60,000 per day and
surpassed 1.4 million unique visitors in December!
(Logo: http://www.newscom.com/cgi-bin/prnh/20090107/CLW051LOGO )
"We are very pleased with the user registration growth of BiomedExperts as
well as the accolades that we are receiving from the industry," stated Bill
Kirkland, CEO of Collexis Holdings, Inc. "As our user registration base grows
along with our page views, BiomedExperts is poised to become the industry
standard for life science researchers. We are looking forward to the future
releases of BiomedExperts and the launch of new portals across the other
scientific disciplines and industries."
Research and advisory firm Outsell, Inc. selected BiomedExperts as one of
the top 10 social communities to watch in 2009, in its report "Social Media in
STM Part 1: Social Networking"
(http://www.outsellinc.com/store/products/792?refid=prcol792). A recent
Elsevier study found after only seven months post launch, BiomedExperts was
the second most frequently used life science social network behind Nature but
ahead of Facebook, MySpace and LinkedIn. Also the launch announcement of
BiomedExperts was the #1 headline on the eHealthNews.EU news portal for 2008.
Pre-populated with over 1.8 million Pub-Med-based expert profiles,
BiomedExperts allows scientists and researchers to directly connect with and
explore their own professional contacts, grow their networks and identify
researchers with the expertise needed for future collaborations. Through
user-friendly search interfaces, potential research collaborators can share
data and collaborate with professionals from more than 1,800 organizations and
institutions from 137 countries, totaling more than 21 million connections
made through the site.
About Collexis Holdings, Inc.
Collexis Holdings, Inc., a leading developer of semantic search and
knowledge discovery software is headquartered in Columbia, South Carolina
(USA) with operations in Cincinnati, Ohio and Cologne, Germany. Collexis now
offers the world's first pre-populated scientific social network for life
science researchers, http://www.biomedexperts.com . Collexis' proprietary
technology builds conceptual profiles of text, called Fingerprints, from
documents, Websites, emails and other digitized content and matches them with
a comprehensive list of pre-defined "fingerprinted" concepts to make research
results more relevant and efficient. This matching of concepts eliminates the
ambiguity and lack of priority associated with word searches. The results are
often described as "finding needles in many haystacks." Through this novel
approach, Collexis can build unique applications to search, index and
aggregate information as well as prioritize, trend and predict data based on
sources in multiple industries without the limitations of language or dialect.
Collexis' current clients in the public, private and academic sectors include
the Mayo Clinic; Johns Hopkins University; Dana-Farber Cancer Institute, the
University of California, San Francisco; the University of South Carolina;
Erasmus University Library; Bristol-Myers Squibb; Lockheed Martin; the World
Health Organization; Wellcome Trust; the National Institutes of Health; and
the U.S. Department of Defense. Shares of Collexis common stock are traded
under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more
information, visit http://www.collexis.com .
Forward-Looking Statements
Some of the statements made in this press release may constitute forward-
looking statements within the meaning of the Private Securities Litigation
Reform Act of 1995. These forward-looking statements are based on management's
current expectations and include known and unknown risks, uncertainties and
other factors, many of which the company is unable to predict or control, that
may cause the company's actual results or performance to differ materially
from any future results or performance expressed or implied by such forward-
looking statements. These statements involve risks and uncertainties,
including risks and uncertainties associated with BiomedExperts.com. These
risks and uncertainties are in addition to other factors detailed from time to
time in the company's filings with the SEC, including the section entitled
"Risk Factors" in its transition report on Form 10-KSB for the period ended
June 30, 2008. The company cautions investors that any forward-looking
statements made by the company are not necessarily indicative of future
performance. The company is not responsible for updating the information
contained in this press release beyond the published date, or for changes made
to this document by wire services or Internet services.
SOURCE Collexis Holdings Inc.